Chitosan is a natural cationic linear polymer that has recently emerged as an alternative nonviral gene delivery system. We have established the relationships between the structure and the properties of chitosan-pDNA polyplexes in vitro. Further, we have compared polyplexes of ultrapure chitosan (UPC) of preferred molecular structure with those of optimised polyethylenimine (PEI) polyplexes in vitro and after intratracheal administration to mice in vivo. Chitosans in which over two out of three monomer units carried a primary amino group formed stable colloidal polyplexes with pDNA. Optimized UPC and PEI polyplexes protected the pDNA from serum degradation to approximately the same degree, and they gave a comparable maximal transgene expression in 293 cells. In contrast to PEI, UPC was non toxic at escalating doses. After intratracheal administration,
Introduction
Several of the most effective nonviral DNA delivery systems are based on cationic polymers such as polyamidoamine dendrimers 1 and polyethylenimine. 2 However, these polymers are synthetic and not biodegradable, which means that their potential toxicity is a concern. Biodegradable cationic polypeptides such as poly(lysine) and protamine generally form polyplexes whose transfection efficiencies are lower than those of the dendrimers and PEI. [3] [4] [5] Chemical modification with a targeting ligand 6 or the inclusion of another DNA-condensing compound, such as a cationic lipid, 7 in the formulation, is required to obtain an acceptable transgene expression. Further, some biodegradable polypeptides, for example poly(lysines), may be toxic. 8 Against this background we decided to investigate alternative biocompatible cationic polymers that form nontoxic polyplexes and that give both polyplexes distributed to the mid-airways, where transgene expression was observed in virtually every epithelial cell, using a sensitive pLacZ reporter containing a translational enhancer element. However, the kinetics of gene expression differed -PEI polyplexes induced a more rapid onset of gene expression than UPC. This was attributed to a more rapid endosomal escape of the PEI polyplexes. Although this resulted in a more efficient gene expression with PEI polyplexes, UPC had an efficiency comparable to that of commonly used cationic lipids. In conclusion, this study provides insights into the use of chitosan as a gene delivery system. It emphasises that chitosan is a nontoxic alternative to other cationic polymers and it forms a platform for further studies of chitosan-based gene delivery systems. Gene Therapy (2001) 8, 1108-1121.
high transgene expression in vivo. Ideally, such polymers should have well-defined chemical characteristics and possess the following properties: (1) a DNA-condensing capacity that generates complexes that are sufficiently small to allow an even tissue distribution and subsequent endocytosis; (2) endosomolytic properties that allow endosomal escape of the DNA; (3) biocompatibility; (4) simple synthesis and purification that allows largescale manufacture; and (5) functional groups that allow simple coupling of extracellular and intracellular targeting ligands. [9] [10] [11] [12] A survey of the literature indicated that chemically modified cationic polysaccharides such as APL PolyCat57 13 and chitosan 12, 14 may fulfil many of these requirements.
Of particular interest is chitosan, which is derived by partial deacetylation of chitin from crustacean shells. It is a linear biodegradable polysaccharide comprised of randomly distributed beta [1] [2] [3] [4] bound N-acetylglucosamine and d-glucosamine, and it is considered to be nontoxic after oral administration to humans. 15 It has been approved as a food additive and has been incorporated into a wound-healing product. 16 In a promising study (published during the course of this work), chitosan-More importantly, oral administration of the chitosan formulation carrying a plasmid that encodes a peanut allergen induced tolerance against peanut allergy in a challenge model. 17 However, this study conflicts with several other investigations, which have found chitosan to be a relatively inefficient gene delivery system in vitro and in vivo. 18, 19 Thus, the factors that determine the effectiveness of chitosan-based gene delivery systems need to be clarified.
This study was designed to provide further insight into the in vitro and in vivo properties of chitosan as a DNAcondensing nonviral gene delivery system. First, chitosans of different, well-defined chemical structures were produced in order to establish structure-property relationships with regard to polyplex formation and in vitro transfection efficiency. The chitosan formulation having the most desirable properties was further characterised with regard to biodegradability and stability. Second, the morphology, toxicity and transfection efficiency of an optimised ultrapure chitosan formulation was compared with those of an optimised PEI-formulation in vitro. Third, the distribution of the optimized chitosan formulation after intratracheal administration was investigated, and the kinetics of gene expression of chitosan and PEI polyplexes were compared. As part of this work, the target cells were identified. Finally, the mechanism behind the differences in kinetics of gene expression between chitosan and PEI polyplexes were studied.
Results

Structure-property relationships
The chitosan structure can be varied in two ways, by changing the degree of acetylation of the glucosamine monomers, ie the charge of the polymer, or by changing the molecular weight. The chitosans (C) were defined by a previously published nomenclature in which C is followed by two numbers within brackets. 20 The first number gives the degree of acetylation in % and the second number the molecular weight in kDa. Five chitosans having mean molecular weights ranging from 31 to 190 kDa with different degrees of de-acetylation, corresponding to 99%: C(1;31) and C(1;170), 85%: C(15;190), 65%: C(35;170) and 51%: C(49;98) of the glucosamine monomers having a primary amine, respectively, were produced to investigate relevant structure-property relationships. The chitosans were complexed with pCAT at different charge ratios and tested for complex stability and transfection efficiency in 293 cells.
All five chitosans formed colloidal particles of similar sizes when mixed with pDNA (Table 1) . However, only the chitosans with high charge densities, formed stable complexes with pDNA in a gel retardation assay ( Figure  1a) . Thus, at charge ratios у1.8:1 (+/−), C(15;190) retained most of the pDNA on the gel. Comparable results were obtained with the most highly charged chitosan C(1;170) (data not shown). In contrast, only partial retention of pDNA was observed with C(49;98), a chitosan having priGene Therapy mary amino groups only on every second monomer unit ( Figure 1a ). Comparable results were obtained for C (35;170) . The in vitro transfection efficiency of the differently charged polyplexes correlated strongly with the formation of stable polyplexes. Only polyplexes that are completely retained on the agarose gels gave a modest but significant transgene expression in 293 cells as compared with naked DNA (Figure 1b) . Thus, a 36-and 70-fold higher transgene expression was obtained with the C (15;190) formulation as compared with the C(35;170) and C(49;98) formulations at optimal charge ratios around 3:1 (+/−) ( Table 1) . The stability and the in vitro transfection efficiency of chitosans did not depend on molecular weight in the range from 31 to 170 kDa. C(1;31) and C(1;170) gave colloidal particles of comparable sizes, were retained on the agarose gel at comparable charge ratios, and gave comparable transgene expressions in 293 cells (Table 1) . Similar results were obtained when the corresponding chitosans having 85% of their monomer units positively charged were compared.
In summary, the percentage of positively charged monomers in chitosan must be greater than 65% in order to form physically stable complexes that transfect target cells in vitro. Based on these studies, a commercial ultrapure chitosan (UPC) in which 83% of the monomers had primary amines was selected for further studies.
Optimisation of ultrapure chitosan polyplexes
The performance of the UPC (C(17;162)) polyplexes was comparable to that of the structurally similar C(15;190) polyplexes in Figure 1 (data not shown). Two days after transfection, the highest gene expression was obtained at a charge ratio of 2.4:1 (+/−), giving a modest CAT expression of 6.8 ± 1.2 pg/g protein. Surprisingly, much higher expression levels were obtained 6 days after transfection (Figure 2 ). At charge ratios of у1.2 (+/−) the CAT gene expression reached a plateau with a CAT expression of 25.7 ± 6.1 pg CAT/g protein. Similar results were obtained when the amount of chitosan was kept constant and the amount of pDNA was varied. Finally, the dosedependent transgene expression in 293 cells was studied at a charge ratio of 2.4:1 (+/−). The dose-response curve showed a steep increase up to 1.5 g per well where a plateau was reached (data not shown). Based on these results chitosan polyplexes having a charge ratio of 2.4:1 (+/−) were used at a dose of 2 g pDNA/well in the in vitro studies described below.
Stability of chitosan polyplexes
The stability of the UPC polyplexes was examined by incubation with an excess of salt (sodium chloride, 3.5 m), detergent (sodium dodecyl sulphate, 0.5 m) and a poly(anion) (heparin, 10-fold excess of negative charges). None of these conditions released the pDNA from the chitosan, indicating that very strong hydrophobic bonds are formed between pDNA and the polysaccharide. Incubation with the chitosan-degrading enzyme chitosanase (120 mU; 5 h), released all pDNA from the complexes ( Figure 3A) . A reduction of the fraction of supercoiled pDNA was observed after the release. However, a comparable reduction of supercoiled pDNA was observed when 'naked' pDNA was incubated with chitosanase, indicating that the chitosanase rather than the complex formation with chitosan affected the pDNA conformation. A slight retardation of both open-circle and supercoiled pDNA was observed in all samples containing degraded chitosan, suggesting that molecular fragments of chitosan remained associated with the pDNA. Incubation of UPC polyplexes at a charge ratio of 3:1 (+/−) in the presence of DNaseI (8 U, 1 h) showed that the pDNA was protected from DNase degradation ( Figure 3B ).
Comparison of UPC and PEI polyplexes
The properties of UPC polyplexes in vitro and in vivo were compared with that of optimised PEI polyplexes. PEI polyplexes were selected since they have consistently been regarded as one of the most efficient nonviral gene delivery systems. 21 High molecular weight PEI (800 kDa) at a charge ratio of 9:1 (+/−) was used for the in vitro studies since PEI (800 kDa) may be more effective than PEI of lower molecular weight in vitro. 22 In contrast, several reports indicate that low molecular weight PEI (25 kDa) at a charge ratio of 4:1-6:1 (+/−) is more effective than PEI (800 kDa) in vivo. 23, 24 Therefore, all in vivo comparisons were performed against the low molecular weight PEI at a charge ratio of 5:1 (+/−). 25 In vitro studies: In order to investigate whether UPC protects the pDNA against degradation by endogenous enzymes, the charge-dependent stability and transgene expression in 293 cells were investigated in the presence of serum. When naked DNA or UPC polyplexes were incubated with 10% serum, the pDNA was fully retained on the agarose gel at charge ratios of 3 (+/−) or larger, indicating that the polyplexes gave significant protection against the serum nucleases. Comparable stability and transgene expression were obtained with PEI polyplexes incubated with 10% serum ( Figure 3C ). The levels of transgene expression in 293 cells were about 60% of those obtained in the absence of serum, suggesting that the pDNA was partially inactivated and/or that the uptake of polyplexes by the cells was lower in the presence of serum.
The diameters of UPC and PEI polyplexes were comparable, 120 ± 9 nm and 111 ± 15 nm, respectively. UPC Gene Therapy polyplexes had a higher surface charge (zeta potential) (18.8 ± 0.4 mV) at the optimal charge ratio than PEI (7.6 ± 0.3 mV). Morphological examination of the polyplexes using transmission electron microscopy (TEM) and cryo-TEM gave comparable results (Figure 4 ). PEI polyplexes were spherical with a relatively homogenous size which agrees with previous results. 4 UPC formed complexes of a more heterogenous morphology although the structures appeared to be more ordered than those observed previously. 14 The acute cell toxicities of the UPC and PEI polyplexes were compared by studying the dose-dependent effects on intracellular dehydrogenase activity in 293 cells. Both polyplexes were nontoxic at the concentrations used for in vitro transfection studies (0.5 g pDNA, corresponding to 12.6 g/ml UPC and 6.4 g/ml PEI in 96-well plates) ( Figure 5A ). However, at concentrations greater than 20 g/ml PEI, PEI polyplexes were clearly toxic in a manner that depended on the dose, with an IC 50 value of 75 g/ml. In contrast, a dose of UPC polyplexes of 630 g/ml UPC was required to obtain a modest 20% reduction in dehydrogenase activity, indicating that the UPC polyplexes had a lower toxicity in this assay. The difference in toxicity between UPC and PEI was also evident when the effects of the free polymers were studied in the same assay, giving an IC 50 value of 62 g/ml for PEI and a 20% reduction in dehydrogenase activity at 0.5-1 mg/ml for UPC. There was no difference in toxicity between PEIs with molecular weights of 25 kDa and 800 kDa (data not shown).UPC (C(17;162)) was compared with the structurally similar chitosan C(15;190) in order to evaluate the effect of chitosan purity on its toxicity. C(15;190) was significantly more toxic than UPC, and 
Figure 5 Comparison between UPC (2.4:1 +/−) and PEI 800 kDa (9:1 +/−) polyplexes on (A) the acute cellular toxicity and (B-D) in vitro transfection efficiency. (A) The effect of UPC () and PEI (ț) polyplexes on the viability of 293 cells was determined by the MTT assay. The arrow indicates the corresponding concentration used for in vitro transfection studies. Naked pDNA (̆) was used as control (n = 8). (B) Time course studies of CAT gene expression in 293 cells after incubation with UPC () and PEI polyplexes (ț) (n = 4). (C) Qualitative evaluation of the percentages of 293 cells transfected with UPC (25%) or PEI (35%) polyplexes 144 h after transfection using GFP as the reporter gene. Bars indicate 10 m (n = 4). (D) CAT gene expression in different cell lines (293, HT-1080 and Caco-2) 144 h after incubation with UPC (filled bars) and PEI (open bars) polyplexes (n = 4). Results are expressed as mean values ± s.d. from one representative experiment of three performed.
affected the intracellular dehydrogenase activity in a dose-dependent manner, with an IC 50 value of 0.5 mg/ml. The toxicity of C(15;190) was thus about seven times lower than that of PEI. This difference was not caused by endotoxin contamination, since no endotoxins could be detected in solutions of UPC, C(15;190), PEI or sterile water (Ͻ0.03 EU/ml). UPC and PEI polyplexes displayed different kinetics of gene expression in 293 cells ( Figure 5B ). The onset of gene expression using UPC polyplexes was slower than that of PEI polyplexes ( Figure 5B ), which agrees with the results presented in Figure 2 . However, the gene expression obtained with the UPC formulation increased over time, and after 120-144 h a transgene expression of about 25 pg CAT/g protein was obtained with both of the polyplexes. The percentage of transfected cells was found to be slightly lower for UPC (25%) than for PEI (35%) ( Figure 5C ). To further compare the in vitro transfection efficiencies of the optimised UPC and PEI polyplexes, the transgene expression was studied in two other cell lines, HT-1080 and Caco-2. A clear cell line dependence was observed ( Figure 5D ). PEI gave a higher transgene expression than UPC in both cell lines, including the highly differentiated Caco-2 cell line.
In vivo studies: The effects of UPC (3:1) and PEI (25 kDa, 5:1) polyplexes in vivo were compared after intratracheal administration to mice, using beta-galactosidase and luciferase as reporter genes. A new mild evaporation method was developed that concentrated the polyplexes to minimize the administered volume. This method concentrated the UPC and PEI polyplexes up to 60 times (to a concentration of 3 mg/ml) after 105 min, without any loss in transfection efficiency (Table 2) . However, UPC polyplexes were slightly larger at higher concentrations and the viscosity increased. Therefore, UPC and PEI polyplexes of concentrations of 0.5 mg/ml were used for intratracheal administration.
Preliminary studies showed that intratracheal administration of UPC polyplexes at a charge ratio of 3:1 (+/−) gave seven-and nine-fold higher gene expressions than UPC polyplexes having charge ratios of 1.2:1 (+/−) and 6:1 (+/−), respectively, 72 h after dosing. Administration of UPC polyplexes 3:1 (+/−) at two doses corresponding to 25 and 50 g of pLuc, respectively, gave a level of gene expression of 97 ± 18 pg per mg of lung tissue protein for the higher dose, and 37 ± 7 pg per mg lung tissue protein for the lower dose (P Ͻ 0.02). UPC polyplexes having a charge ratio of 3:1 (+/−) and a dose corresponding to 50 g pDNA were therefore used for intratracheal administration.
Intratracheal administration of fluorescently labeled UPC polyplexes 3:1 (+/−) showed that the polyplexes were mainly localised to the epithelial cells lining the trachea and the bronchioles of the mid-airways 10 min after administration ( Figure 6 ). However, the polyplexes were associated in the trachea with an extracellular fuzzy structure (probably the mucus layer), located above the epithelial cell layer. Since PEI quenched the fluorescence emitted from the psoralen-labeled pDNA, the PEI poly- plexes could not be identified in the corresponding experiment. However, recent studies of PEI polyplexes of an identical composition indicate a similar lung distribution to that of the UPC polyplexes in the present study. 25 A qualitative assessment of the gene expression in the lungs was obtained using a new efficient plasmid (pBK-SFVB7-LacZ) that contains a translational enhancer element. 26 The gene expression was surprisingly strong in the mid-airways 72 h after administration of a 50 g dose of pLacZ in both UPC and PEI polyplexes, indicating that both polyplexes were highly effective as compared with naked DNA (Figure 7) . A patchy pattern of gene expression was sometimes observed, and it was probably caused by the simple administration method, which made co-ordination between breathing and the dropwise administration of the formulation difficult. In general, after administration of naked DNA, no gene expression was observed. However, a small, single, weakly stained patch of blue colour was observed in some mice. No gene expression at all was observed when UPC polyplexes containing a nonsense pLuc plasmid were administered (data not shown). Cryosectioning of the lung tissues showed that virtually all epithelial cells lining the bronchioli in the mid-airways expressed the transgene after administration of the UPC and PEI polyGene Therapy plexes. Very few cells were transduced in the lower airways or in the trachea.
Finally, the time courses of gene expression for UPC and PEI polyplexes were compared. Onset of gene expression was rapid following administration of PEI polyplexes, peaking after 24 h at a maximal value of 1.5 ± 0.3 ng per mg lung tissue protein ( Figure 8 ). In contrast, gene expression onset was slower with UPC, with a maximal gene expression at 48-72 h and a rapid decline at day 5. The level of gene expression with PEI was significantly higher than that of UPC polyplexes at all time points, and the highest gene expression obtained with UPC was approximately three times lower than the corresponding gene expression for PEI polyplexes.
Buffer capacity and endosomal release
The high effectiveness of PEI polyplexes has been generally attributed to the high buffering capacity of PEI, especially at the slightly acid pH that is found in the endosomal vesicles. 4, 27, 28 We therefore compared the buffering capacity of PEI with that of chitosan ( Figure 9A ). In agreement with previous findings, PEI displayed a high buffering capacity over a wide pH range. 4 In contrast, the buffering capacity of chitosan was modest, and restricted to the pH interval between 5 and 7. Since it has been speculated that a major effect of the high buffer capacity of PEI is rupture of the endosomal membrane, we examined the endosomal morphology of 293 cells transfected with naked DNA, UPC and PEI polyplexes at different time points (Figure 9B-E) . Naked DNA did not affect the endosomal membrane at either of the time-points studied (24 and 72 h) ( Figure 9B ). At 24 h after transfection with PEI polyplexes, the endosomal compartments were filled with PEI polyplexes, but the endosomal membranes were clearly affected and ruptured ( Figure 9C) . At 24 h, UPC polyplexes were also localised in bilayered, endosomal compartments, but no effect on the endosomes could be observed ( Figure 9D) . However, at 72 h the endosomal membranes of UPC-transfected cells displayed irregularities and breaks ( Figure 9E ), comparable to those observed with PEI polyplexes after 24 and 72 h ( Figure  9C ). In conclusion, the onset of endosomal rupture differed between the two polyplexes and coincided with the onset of gene expression, suggesting that the endosomal release is a rate-limiting step for both PEI and chitosan polyplexes. 
Discussion
In this study, the effects of the two structural variables of chitosan polymers on their effectiveness as a complexing agent for plasmid DNA were studied for the first time. For this purpose we produced and purified chitosans that were well-defined with regard to the degree of acetylation and polydispersity. Thus, in our chitosans, the acetyl groups are randomly distributed, which is a prerequisite for a direct comparison between chitosans of different molecular weights. 29 Moreover, a stringent purification procedure gave chitosans of a low polydispersity, 30 ie a more narrow molecular weight distribution as compared with previously studied chitosans in this research field. 14, 19 We found that stable polyplexes capable of transfecting 293 cells in vitro were formed only when the chitosans had a high density of positive charges, ie a primary amino group on more than two out of three monomer units was required to obtain stable polyplexes. This agrees with the fact that complexes between cationic polymers and anionic pDNA are predominantly formed by ion-ion interactions. 4 Further, highly charged chitosans have a favorable, extended conformation with a flexible chain, while chitosans of a lower charge density have a more coiled shape. 31 The formation of stable polyplexes was less sensitive to the second structural variable, the chitosan chain length, in the investigated size interval. The shortest chitosans contained a sufficiently large number of positive charges to compact the pDNA in the same way as the longer chitosans. A further size reduction will be necessary in order to obtain polymer chains with properties intermediate between those of the long polyions of the present study and the extensively studied multivalent ions. 32 Preliminary results from our laboratory suggest that such shorter polyions are interesting both from a fundamental and from a practical point of view, since they may retain the advantageous properties of both long polyions (such as the formation of stable complexes) and of multivalent ions. 33 During the course of this study, an ultrapure chitosan (UPC) that satisfied the structural criteria outlined above became available. We selected UPC as a representative chitosan for the present study because this allowed us to minimize the effects of unknown contaminants or adjuvants on the interpretation of the results. To our knowledge, previous studies of chitosans and many other cationic polymers have mainly been based on less welldefined or roughly processed bulk chemicals without 
. After 24 h, the membranes of endosomal compartments filled with PEI polyplexes (C) showed irregularities and breaks compared with those filled with UPC polyplexes (D). However, 72 h after transfection endosomal membranes containing UPC polyplexes were shown to be affected (E). As control, 293 cells transfected with naked DNA were used (B). Original magnification, × 7000 (B), × 3200 (C) and × 11000 (D and E). Representative micrographs from three independent experiments are shown.
consideration of their purity. The different qualities of these materials could therefore have contributed to the discrepant results reported for these compounds, for example, the results concerning efficiency and toxicity.
Our optimized chitosan polyplexes were stabilized by strong hydrophobic and/or hydrogen bonding forces, since neither excessive amounts of salt, detergent or another polyanion, heparin, could dissociate the polyplexes. 4 The pDNA was released only after incubation
Gene Therapy with a chitosan-degrading enzyme. This high physical stability has important implications. First, the pDNA in the chitosan polyplexes was protected from degradation by nuclease and serum. Second, since the release of pDNA from the polyplexes was found to be dependent on enzymatic degradation, the release will occur mainly at sites where chitosan-degrading enzymes are present. In animal cells, chitosan is degraded into oligomers by lysozyme, and then further degraded by N-acetyl-glucosaminidase. 34 Both of these enzymes are present in the endosomal/lysosomal vesicles, which means that the degradation and release of pDNA will start immediately after endocytosis of the chitosan polyplexes. Since lysozyme is present in many other body fluids, and it is especially abundant at sites of inflammation, it can be speculated that chitosan polyplexes could be used to release pDNA exclusively at such sites.
Although chitosan has been reported to have a low toxicity, reviewed by Illum, 16 a few investigators, including us, have observed a dose-dependent toxicity of chitosans at high doses in vitro. 20, 35 The present study found that an ultrapure chitosan, UPC, was essentially nontoxic, while the corresponding chitosan produced in our laboratory C(15;190), had a low but detectable in vitro toxicity at high doses. This suggests that the toxicity most likely is due to impurities in the chitosans. This result underscores the importance of considering not only pDNA purity, 36 but also the quality of the other components of a gene delivery system. The toxicity of C(15;190) was seven times lower than that of PEI, supporting the suggestion that chitosan may be a nontoxic alternative to PEI. However, it should be noted that all studies in the present investigation were performed at nontoxic concentrations of the polyplexes, as assessed by the mitochondrial dehydrogenase assay. We therefore conclude that the toxicity of the polymers is not an issue in the present study.
Any new gene delivery system should be compared to a state-of-the-art delivery system, before being considered as an alternative. However, information regarding the efficiency of chitosan as compared with other gene delivery systems is scarce. One in vitro study found that chitosan was less efficient than PEI in the absence of serum, but slightly more efficient in the presence of 10% serum.
14 Two other, independent in vitro studies found that chitosan was less efficient than lipofectamine. 12, 19 In contrast, in the latter study, chitosan was found to be slightly more effective than lipofectamine in vivo after dosing to the upper small intestine in rabbits. 19 We therefore compared the in vitro and in vivo efficiencies of UPC with those of PEI polyplexes, which is considered to be one of the most effective polymeric nonviral gene delivery systems, with an efficiency that is equal to or better than those obtained with delivery systems based on cationic lipids. 3, 27 Studies in 293 cells using the stable reporter gene CAT showed that the kinetics of gene expression were clearly different following administration of PEI and UPC polyplexes. The former induced a more rapid onset of the transgene expression. However, at later time points, the CAT expression was comparable between the two polyplexes. Disappointingly, UPC polyplexes were less efficient than PEI in more differentiated epithelial cell lines such as HT-1080 and Caco-2. There are many possible reasons for this difference. It may be due to physical differences, eg in shape and charge resulting in different binding and uptake kinetics or it may be due to cell-line dependent differences. Two examples of such differences are varying contents of chitosan-degrading enzymes in the endosomal compartments and differences in the ratelimiting barriers to transgene expression. It is difficult to elucidate cell-line-dependent differences in transgene expression, and so we decided to study the efficiency of the UPC polyplexes in differentiated airway epithelial cells in vivo.
The intratracheal route of administration was chosen because of its accessibility, its therapeutic relevance for gene delivery, especially in cystic fibrosis, and because it has been used in studies of many other nonviral delivery systems. This makes it possible to compare previous results with the results in the present study. PEI and UPC were used at optimal charge ratios of 5:1 and 3:1, respectively, based on literature data 25, 37 and on our preliminary in vivo experiments. It is also worth noting that intratracheal administration of PEI polyplexes at a charge ratio of 5:1 did not result in an inflammatory response, as had occurred at higher charge ratios. 37 Since intratracheal installation of large volumes of liquids may result in asphyxiation, we devised a simple and mild method to concentrate the polyplexes without concomitant aggregation. This method used mild evaporation of the diluted polyplex solutions during centrifugation. In our hands, other, conventional concentration methods, such as gas evaporation or conventional ultrafiltration, resulted in irreversible aggregation and/or unacceptable losses of complex in the filter. Preliminary results show that our method may also be used with other diluted nonviral delivery systems, suggesting that it is generally applicable for the concentration of electrostatically stabilised colloidal solutions of nonviral gene delivery systems.
Shortly after administration, the psoralen-labeled UPC polyplexes distributed to the epithelial surfaces of the mid-airways, an ideal target for the treatment of cystic fibrosis. 38 We could not follow the distribution of correspondingly labeled PEI polyplexes due to quenching, but a recent publication on the lung distribution of the same PEI formulation (25 kDa, 5:1) showed a comparable distribution to the mid-airways. 25 In general, the X-gal staining pattern after administration of PEI and UPC polyplexes of a pLacZ reporter gene agreed with the distribution studies using psoralen-labeled polyplexes. Large patches were found in which virtually every epithelial cell lining the mid-airways expressed the reporter gene. For all formulations, the locations of these large patches varied from one lung to another, indicating difficulties in co-ordinating the drop-wise administration of the polyplexes with the respiration. We believe that administration of the polyplexes by an aerosol device will eliminate the variability in the distribution patterns. Interestingly, UPC and PEI appeared to be equally effective in transfecting the airway epithelium in the lung, in contrast to the findings in vitro. These results indicate that optimised UPC or PEI formulations give strong transgene expression patterns in the majority of differentiated airway epithelial cells. The results also show that plasmids that contain translational enhancer elements 26 may be excellent reporter genes in combination with conventional reporters such as LacZ. However, an adjuvant gene delivery system is required, even for this highly efficient plasmid, since no gene expression was observed when the corresponding amount of pLacZ was administered in free form.
The psoralen-labeled UPC formulation was also found in the trachea, but no LacZ gene expression was observed in this organ. This is consistent with the observed association of the UPC formulation with a putative mucus layer, rather than with the epithelial cells, and also with previous results that indicate that the mucus layer in the rat small intestine may block the interaction between chitosan and the intestinal epithelium. 39 Since the mucus layer also reduces the efficiency of other nonviral and adenoviral gene delivery systems, 40 this finding must be kept in mind if chitosan is to be considered as an alternative delivery system in cystic fibrosis patients, who have a thick and highly viscous mucus layer. 41 However, further studies are needed in this area since in other studies, a chitosan-based delivery system gave a high gene expression in the intestine after oral administration to mice, despite the presence of a thick mucus barrier adjacent to the intestinal epithilium in the mouse intestine. 17 The promising qualitative in vivo results using LacZ as a reporter gene motivated us to compare the kinetics of reporter gene expression after intratracheal administration of the UPC and PEI polyplexes. Bearing in mind that our previous results were obtained with the stable reporter proteins CAT and beta-galactosidase, which have intracellular half-lives of 50 and 48 h, respectively, 42, 43 we challenged the efficiency of the chitosan polyplexes by using the much less stable luciferase (halflife approximately 3 h) 42 as a reporter. As in the kinetic studies in vitro, PEI polyplexes of pLuc induced a much more rapid onset of transgene expression in the lung tissue than the UPC polyplexes, with maximal gene expression as high as 1500 pg pLuc per mg lung protein after only 24 h. The pLuc expression peaked at 100 pg pLuc per mg lung protein 48-72 h after administration of UPC polyplexes, which is about 10 times higher than that obtained with naked pLuc. These values can be compared with reported peak values for various cationic lipoplexes, using the same administration route. In two studies, optimised DOTMA-based lipoplexes gave maximal transgene expressions comparable to those observed for the UPC polyplexes (80-200 pg per mg protein). 44, 45 The second-generation cationic lipid GL-67 displayed a higher transgene expression in an initial study, 46 but this result has not been confirmed in later studies, where maximal gene expressions comparable to those of DOTMA and UPC have been reported. 47 The high efficiency of PEI may be due to its high buffering capacity in the endosomal compartment, which leads to positively charged ions being trapped by the amines in PEI, enhanced osmolarity and subsequent endosomal rupture and escape into the cytoplasm. 18, 27 The high efficiency may also be due to enhancement of transgene transport from the cytoplasm to the nucleus. 3 To get some mechanistic insight into the differences in efficiency between UPC and PEI, we compared their buffering capacity and endosomal escape. In contrast to PEI, 4 UPC displayed no buffering capacity at the acid endosomal pH-interval of 4.5-5.5. This is consistent with the fact that the buffering capacity of UPC is provided by primary amines with an unusually high pKa-value of 6.5 48 and indicates that chitosan does not act as a sponge for protons and other cations in the endosomal compartment in a manner comparable to PEI. Enzymatic degradation is therefore a more likely mechanism for the endosomal escape of UPC polyplexes. The degradation products (oligo-and monosaccharides) will increase the osmolarity, and this increase will be followed by water influx and subsequent swelling and rupture of the vesicular membranes. 49 Indeed, we used the assumptions applied by Zabner et al 50 when they determined the endosomal uptake of lipoplexes, to calculate the endosomal concentration of UPC. We calculated that complete degradation of UPC would result in a concentration of the monomers in the endosomal compartment of 2-6 m, which would give an enhanced osmolarity far above that required for endosomal release.
We hypothesised that whatever the mechanism, the efficiency of the PEI and UPC polyplexes would depend on the rates at which the two polymers escaped from the endo/lysosomal compartment. The observed relationship between the time of appearance of ruptured endosomal membranes and the appearance of transgene expression in 293 cells gives strong support for this hypothesis and provides an explanation for the more rapid onset of CAT and luciferase expression obtained with PEI in vitro and in vivo.
Surprisingly, a clear difference in the decline of gene expression was also observed. After UPC-pLuc administration, the luciferase expression decreased rapidly after a few days in a manner typical of other nonviral gene delivery systems, such as cationic lipids. 46, 51 In contrast, the decline was much slower after administration of PEIpLuc, suggesting that PEI has a unique stabilizing effect on the expression of the short-lived enzyme. These results were confirmed in 293 cells, indicating that PEI stabilized the expression of luciferase in at least two different cell types (data not shown). Whether the stabilizing effect is related to the fact that PEI remains bound to the pDNA also after transport across the nuclear membrane 52 or to any other unique property warrants further investigation. In summary, the in vivo results support the idea that PEI is one of the most efficient nonviral gene delivery system for lung administration, while chitosan has an efficiency that is comparable to that of well-established gene delivery systems based on cationic lipids. However, since chitosan lends itself to chemical modification, we suggest that the efficiency of this gene delivery system can be enhanced. We also note that the efficiencies of chitosan in vitro and in vivo are much higher than those of many other cationic polymers that have recently been put forward as alternative gene delivery systems. 53, 54 Finally, the results suggest that chitosan is as effective as PEI when used together with stable transgenes.
In conclusion, the results of the present study define the structural requirements on chitosan as a gene delivery system and indicate that chitosan possesses many characteristics of an ideal gene delivery system. It is biodegradable and nontoxic, provided that it is used in a highly purified form. 16 Furthermore, chitosan has an efficiency that is higher than those of most other more or less toxic cationic polymers and comparable to those of preferred cationic lipids. However, our results clearly indicate that PEI remains a more efficient model system for nonviral gene delivery to the lung. We show that this high efficiency is related partly to the rapid endosomal release of PEI and partly to an undefined stabilizing effect on the short-lived reporter luciferase. Nevertheless, concerns regarding the general toxicity of PEI 2 
and its
Gene Therapy potential adverse interactions with host genes in the nucleus, 52 motivate the search for alternative cationic polymers. The results of this study forward chitosanbased polymers as such alternative polymers and form a platform for further investigation and optimisation of chitosan-based gene delivery systems.
Materials and methods
Materials
Plasmids of GMP-grade containing a cytomegalovirus promoter (CMV) and a chloramphenicol acetyltransferase (pCMV-CAT and psoralen-fluorescein-labeled pCMV-CAT) or a firefly luciferase (pCMV-Luc) reporter gene were generous gifts from Valentis, Inc., Burlingame, CA, USA. pGreenLantern-1 plasmid encoding green fluorescent protein driven by the CMV promoter (pCMV-GFP) was purchased from Gibco BRL Life Technologies AB, Täby, Sweden. Plasmids containing a CMV promoter encoding for the beta-galactosidase reporter gene (pBK-SFVB7-LacZ) with a Semliki Forest Virus (SFV) translational enhancer element B7 were prepared and purified as described previously. 26, 55 Chitosans having welldefined degrees of acetylation (DA) and narrow molecular weight distributions were produced and purified as described previously. 56 The chitosans (C) were defined by a previously published nomenclature in which C is followed by two numbers within brackets. 20 The first number gives the degree of acetylation in % and the second number the molecular weight in kDa. Chloride salts of the following chitosans were produced: C(1;31), C(1;170), C(15;190), C(35;170) and C(49;98). Ultrapure chitosan, Protasan UP G 210 (UPC), (endotoxin content Ͻ1500 EU/g, total viable count Ͻ100 c.f.u./g and heavy metal content Ͻ100 p.p.m.), batch No. 902-572-05, was obtained from Pronova Biopolymer, Oslo, Norway. The degree of acetylation of the UPC was 17% and its mean molecular weight was 162 kDa, which means that UPC is denoted by C(17;162). Two types of polyethylenimine (PEI) with molecular weights of 25 kDa and 800 kDa were purchased from Aldrich Sweden, Stockholm, Sweden and Fluka, Buchs, Switzerland, respectively. Chitosanase (chitosan N-acetylglucosamino-hydrolase) from Streptomyces griseus and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) were obtained from Sigma (St Louis, MO, USA). DNase I was purchased from Promega, Madison, WI, USA.
Cells
The human embryonic kidney cell line 293 and the human sarcoma cell line HT-1080 were obtained from ATCC, Rockville, MD, USA, and were maintained according to the supplier's recommendations. The human colorectal carcinoma cell line Caco-2 was maintained as described previously. 57 Formulation of polyplexes Chitosan stock solutions (0.2 mg/ml) were prepared by dissolving chitosan in sterile water at pH 6.1 followed by sterile filtration. For in vitro studies (particle size and zeta potential measurements, gel retardation assays and transfection experiments), different charge ratios (positive amine/negative pDNA phosphate) of chitosan polyplexes were produced at a constant pDNA concentration (13.3 g/ml). The charge ratio was defined as the ratio between the maximum number of protonable primary amines in chitosan and the number of negative phosphates on pDNA. 58 Formulations of UPC were also optimised with regard to in vitro transgene expression by varying the amount of pDNA while keeping the polymer concentration constant. The formulations were then dose-optimised by studying the transfection efficiency at escalating doses.
For in vivo studies polyplexes were constructed as described above at a final pDNA concentration of 50 g/ml in 1 ml sterile MilliQ water. Polyplexes were concentrated by mild evaporation under vacuum in a SpeedVac Plus centrifuge (Savant Instruments, Holbrook, NY, USA) at 1400 r.p.m. for approximately 90 min to obtain DNA concentrations of around 500 g/ml. As a quality control, particle size measurements and in vitro transfection studies using 293 cells were performed on the polyplex batches used in vivo. The charge ratio of UPC polyplexes used for in vivo gene transfer was optimised by varying the amount of polymer while keeping the concentration of pDNA constant. At the optimal charge ratio, two doses of pDNA were studied (25 and 50 g).
PEI stock solutions (10 mm) and PEI polyplexes were prepared as described previously. 27 Optimal charge ratios of 5:1 (+/−) and 9:1 (+/−) for PEI 25 kDa and 800 kDa, respectively, were used throughout. 25, 27, 37 Physicochemical characterisation of polyplexes The diameters of the polyplexes were determined by photon correlation spectroscopy (Zetasizer 4000, Malvern Instruments, Malvern, UK) and their zeta potentials (which indicate the surface charge) were determined by electrophoretic light scattering (Zetasizer IV, Malvern Instruments). The physical stability of the polyplexes was studied by agarose gel electrophoresis (0.8% agarose in TAE buffer).
Morphological characterisation of polyplexes
Polyplexes were examined by cryotransmission electron microscopy (cryoTEM) using a technique described in detail elsewhere. 59, 60 Briefly, a small drop of sample solution (13.3 g/ml pDNA of PEI or UPC polyplexes prepared in sterile MilliQ) was deposited on to a copper grid covered by a holey polymer film. Excess liquid was blotted away with filter paper. The procedure was performed at a controlled temperature (25°C) and controlled humidity conditions in a custom-built environmental chamber. This method produced sample films of thickness between 20-500 nm, spanning the holes in the polymer film. The films were then vitrified by rapid freezing in liquid ethane and transferred to a Zeiss EM 902 transmission electron microscope (Zeiss, Jena, Germany) for examination. The specimens were kept cool, below 108 K, during both the transfer and viewing procedures in order to prevent sample perturbation and the formation of ice crystals. All observations were made in zero-loss bright-field mode at an accelerating voltage of 80 kV.
Samples for conventional TEM were prepared in the same way as those for cryoTEM with the exception that the samples were allowed to dry before examination in a Zeiss EM 902 transmission electron microscope.
Stability of polyplexes and pDNA
The stability of the UPC polyplexes was studied in the gel retardation assay after incubation with increasing amounts of sodium chloride (0.5-3.5 m), sodium dodecyl sulphate (0.05-0.5 m) and heparin (0.01-0.3 g/l) for 20-24 h at room temperature. Chitosan polyplexes or the corresponding amount of naked pDNA (13.3 g/ml) were incubated with 120 mU of chitosanase at 37°C for 5 h as described previously, 61 followed by recovery of pDNA by phenol extraction. Precipitated pDNA was resuspended in sterile water and subjected to agarose gel electrophoresis. 62 pDNA obtained from the stock solution was used as control. The stability of complexed pDNA against DNase degradation was studied by incubation of chitosan and PEI polyplexes in the presence or absence of 8 U of DNase I as described previously. 63 The reaction was carried out for 1 h at 37°C followed by examination using the agarose gel retardation assay. pDNA obtained from the stock solution was used as control.
Determination of the buffer capacity of polymers Chitosan (14 m) and PEI (20 m) were dissolved in 0.15 m KCl to obtain concentrations of 0.5 mg/ml. The buffer capacity of each of the two polycations was determined using pH titration in a Sirius PC101 pK a analyser (Sirius Analytical Instruments Ltd, Forest Row, UK) equipped with an Orion Ross pH electrode (model 8103SC; ATI Orion, Boston, MA, USA). As titrators, 0.5 m HCl and 0.5 m KOH were used. All titrations were made from low to high pH as recommended by the manufacturer.
In vitro gene transfer
Most studies on polyplex-mediated gene transfer were performed in the 293 cell line. Twenty-four hours before transfection experiments, 293 cells were seeded at 70% confluency in 24-well tissue culture plates (Costar, Cambridge, UK). In general, transfections were carried out in serum-free media (Opti-MEM I Reduced Serum Media). 13, 64 Briefly, the cells were washed and 300 l of the indicated polyplex formulations was added per well. After 5 h incubation, the formulations were removed and 1 ml of complete culture medium was added. At indicated time-points, ranging from 12 to 144 h after transfection, cells were washed with PBS (pH 7.4), lysed, harvested and analysed for gene expression. For analysis of CAT expression, the cells were centrifuged, processed and analysed with a CAT ELISA kit (Boehringer Mannheim Scandinavia AB, Bromma, Sweden) according to the manufacturer's instructions. Total cell protein was determined from the lysates using the bichinchoninic acid test (Pierce, Rockford, IL, USA). The medium was changed every second day in experiments studying gene expression for more than 48 h. Each experiment was performed in quadruplicate and results are expressed as mean CAT gene expression per g of total cell protein.
The percentages of transfected 293 cells were studied using UPC and PEI polyplexes with pGFP at optimal charge ratios of 2.4:1 and 9:1 (+/−), respectively. At the end of the 6 days' experiment, cells were washed in PBS (pH 7.4) and fixed in 2-3% paraformaldehyde in PBS for 5 min at room temperature. Cells were then permeabilized using 0.1% Triton X-100 in PBS for 5 min before applying polyclonal rabbit anti-GFP at a 1:500 dilution in PBS containing 0.1% Triton X-100. The cells were washed after 45 min with PBS, and incubated with anti-rabbit FITC (Amersham N1034) 1:100 in PBS containing 0.1% Triton X-100 for 30 min. The slides were washed with PBS, mounted in Dako fluorescent mounting medium (Dakopatts AB, Ä lvsjö, Sweden), sealed and examined under a confocal laser scanning microscope (Leica TCS 4D, Leica LT, Heidelberg, Germany).
Transfection studies with the optimised polyplexes were also performed in HT-1080 and Caco-2 cells. Twenty-four hours before transfection, HT-1080 and Caco-2 cells were seeded at 70% and 30% confluency, respectively, in 24-well tissue culture plates. Cells were incubated with the polyplexes for 5 h and analysed for CAT gene expression 48 and 144 h after transfection as described above.
Intracellular dehydrogenase activity
The effect of polymers and polyplexes on intracellular dehydrogenase activity (a measure of cellular toxicity) in 293 cells was determined by the MTT method as described previously. 65 Calibration experiments showed that the dehydrogenase activity was linearly correlated with the cell number in the range 20 000-100 000 cells/well. Therefore, a cell concentration of 75 000 cells/well was used for toxicity measurements.
Determination of endotoxin content in polymer samples Stock solutions of UPC, C(15;190) and PEI were prepared in sterile water at a concentration of 0.2 mg/ml. The endotoxin contents in the polymer solutions and in sterile water were measured using the Limulus crab methodology according to the European Pharmacopoeia (Council of Europe: Strasbourg, 1997, pp 89-95).
Morphological examination of endosomal membranes
Transfection of 293 cells was performed as described above. The cells were washed with PBS after 24 or 72 h, fixed in 2.5% glutaraldehyde and then immersed in 1% osmium tetroxide and dehydrated with ethanol. Thin sections were stained with uranyl acetate plus lead citrate and examined by transmission electron microscopy in a Philips 420 electron microscope (Philips, Eindhoven, The Netherlands).
In vivo studies
The animal experiments were approved by The Swedish National Board for Laboratory Animals (the local ethical committee in Uppsala). Balb/c mice aged between 6-8 weeks were anesthesized with ketamin/xylazine (5/20 vol%, 0.1 ml/10 g of body weight), and the trachea was surgically exposed with a 0.5 cm long skin incision in the neck. Formulated or naked pCMV-Luc (25 or 50 g in a volume of 100 l) was slowly injected dropwise into the trachea with a 28 G needle in two 50 l portions separated by 5 min to avoid volume-dependent respiratory insufficiency. This procedure resulted in a total administration time of 9-10 min. For studies of luciferase gene expression, mice were killed (CO 2 ) 24, 48, 72 and 120 h after administration of the polyplexes. The lungs were Gene Therapy removed, washed in PBS and 0.3 ml ice-cold luciferase lysis buffer (Promega) with a protease inhibitor coctail (Complete, Boehringer Mannheim Scandinavia) was added. The samples were homogenized for 1 min in a Beadbeater (Biospec Products, Bartlesville, OK, USA), centrifuged at 15 000 r.p.m. at 4°C and mixed with luciferase reagent (Promega). The light emitted during 8 s was measured with a luminometer (Mediators PhL, Mediators Diagnostic Systems, Vienna, Austria). 37, 66 The amount of luciferase expressed was determined from a standard curve prepared with firefly luciferase (Sigma). 67 Each experiment was performed in quadruplicate and the results are expressed as amount of luciferase gene expression per mg of total cell protein (bichinchoninic acid test, Pierce).
The distribution of chitosan polyplexes after intratracheal administration to mice was investigated using psoralen-fluorescein-labeled pCMV-CAT. 45 The mice were killed 10 min after administration and the lungs were removed. The lungs were then frozen in OCT Embedding Medium (Sakura Finetek Europe, Zoeterwoude, The Netherlands), sectioned (5-10 m) in a Leica Jung CM 3000 cryostat (Leica Instruments GmbH, Nussloch, Germany), mounted in Dako fluorescent mounting medium (Dakopatts AB) and examined under a confocal laser scanning microscope (Leica TCS 4D, Leica LT, Heidelberg, Germany).
The expression of beta-galactosidase was studied 72 h after intratracheal administration of UPC and PEI polyplexes of pBK-SFVB7-LacZ as described above. 5-Bromo-4-chloro-3-indolyl-␤-d-galactopyranoside (X-gal) histochemistry was performed as described previously. 37, 68 After staining overnight, the distribution of staining in the whole lungs was determined by macroscopic evaluation. The macroscopic gene expression was documented by placing the lungs in a scanner (AGFA Studioscan II, AGFA-Gevaert, Kista, Sweden). The lungs were then frozen in OCT Embedding Medium (Sakura Finetek Europe). Sections of thickness between 5 and 10 m were cut (Leica Jung CM 3000 cryostat), counterstained with nuclear fast red and visualized under a light microscope (Leica, Wetzlar, Germany) coupled to a digital camera (Nikon Coolpix 900, Nikon Svenska AB, Upplands Väsby, Sweden).
Data analysis
All experiments was performed on a minimum of two occasions using quadruplicate (occasionally triplicate) samples each time. The results from one representative experiment of two or three performed experiments are presented. The gene expression is presented as the amount of the expressed transgene per g (in vitro) or mg (in vivo) of tissue protein. All data are expressed as means ± one standard deviation. Statistical differences between mean values were investigated using ANOVA. Differences between group means were considered significant at P Ͻ 0.05.
